Antibody Cocktail in Moderate to Severe COVID-19 Infection: A Series of 10 Cases

被引:0
|
作者
Bhandari, Rohit Hanmanta [1 ]
Gupta, Sonali [2 ]
机构
[1] Ruby Hall Clin, Dept Neurotrauma Unit, Pune, Maharashtra, India
[2] Sahtyadri Superspecial Hosp, Dept Crit Care Unit, Pune, Maharashtra, India
关键词
Casirivimab; Coronavirus disease 2019; Imdevimab; Remdesivir; Roche's antibody cocktail;
D O I
10.7860/JCDR/2022/56151.16530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the wake of the Coronavirus Disease 2019 (COVID-19) pandemic, scientists all over the world are in a relentless search for a cure. None of the therapies advised till date have shown significant benefit in treating COVID-19 infection. An antibody cocktail consisting of a combination of casirivimab and imdevimab is the newest weapon in the armamentarium against the disease. Currently, it has shown great promise in treating mild non hospitalized cases. The authors present the results of a series of 10 cases aged 18-70 years that demonstrate the efficacy of this cocktail in treating moderate to severe cases as well. All the patients received Roche's Antibody cocktail(C) on admission and standard treatment protocol comprising of remdesivir, methylprednisolone and low molecular weight heparin was given. Oxygen supplementation was titrated to achieve a target SpO(2) of 88-92%. Majority (70%) of the patients demonstrated an improvement in SpO(2)/FiO(2) ratio and a decline in the inflammatory marker levels 3-5 days after receiving the cocktail. Eight out of the 10 patients could be discharged home after 10-14 days of admission. The remaining two had severe disease with Computed Tomography Severity Index (CTSI) >17/25 and died despite receiving all the available therapies. Antibody cocktail is an effective adjuvant therapy against moderate to severe COVID-19 pneumonitis, demonstrating rapid improvement in SpO(2)/FiO(2) ratio, inflammatory markers and a shortened duration of hospital stay.
引用
收藏
页码:UR1 / UR3
页数:3
相关论文
共 50 条
  • [21] Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
    Aouba, Achille
    Baldolli, Aurelie
    Geffray, Loik
    Verdon, Renaud
    Bergot, Emmanuel
    Martin-Silva, Nicolas
    Justet, Aurelien
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1381 - 1381
  • [22] Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases
    Chochol-Labun, Joanna
    Wachnicka-Truty, Renata
    Sinica-Latecka, Malgorzata
    Sikorska, Katarzyna
    Kozinski, Marek
    [J]. CARDIOLOGY JOURNAL, 2021, 28 (06) : 979 - 982
  • [23] Predictors for Severe COVID-19 Infection
    Bhargava, Ashish
    Fukushima, Elisa Akagi
    Levine, Miriam
    Zhao, Wei
    Tanveer, Farah
    Szpunar, Susanna M.
    Saravolatz, Louis
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : 1962 - 1968
  • [24] Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study
    Sheng, Lingshuang
    Wang, Xiong
    Tang, Ning
    Meng, Fankai
    Huang, Liang
    Li, Dengju
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 35 - 39
  • [25] Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study
    Lingshuang Sheng
    Xiong Wang
    Ning Tang
    Fankai Meng
    Liang Huang
    Dengju Li
    [J]. Clinical and Experimental Medicine, 2021, 21 : 35 - 39
  • [26] Clinical Outcomes of Remdesivir in Moderate and Severe Cases of COVID-19: A Retrospective Cohort Study
    Senthiappan, Ruth Priya
    Dambal, Archana A.
    Mohan, K.
    Aithal, Kiran R.
    Parakh, Rajendra Kumar
    Vuppumalla, Bhargav
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : OC36 - OC38
  • [27] COVID-19: A New Severe Infection
    Kalil, Andre C.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2021, 27 (05)
  • [28] No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
    Zheng, Shaoping
    Chen, Qiaosen
    Jiang, Hongbo
    Guo, Chunxia
    Luo, Jinzhuo
    Li, Sumeng
    Wang, Hua
    Li, Huadong
    Zheng, Xin
    Weng, Zhihong
    [J]. OPEN MEDICINE, 2021, 16 (01): : 1403 - 1414
  • [29] Timing of COVID-19 Vaccination and Rates of Severe COVID-19 Infection
    Kucirka, Lauren
    Lessler, Justin
    Manuck, Tracy
    [J]. OBSTETRICS AND GYNECOLOGY, 2023, 141 : 73S - 73S
  • [30] Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection
    Douin, Clara
    Forton, Kevin
    Lamotte, Michel
    Gillet, Alexis
    van de Borne, Philippe
    [J]. HEALTHCARE, 2022, 10 (10)